![Elissa Cote](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elissa Cote
Corporate Officer/Principal chez
VISTAGEN THERAPEUTICS, INC.
Profil
Elissa Cote currently works at Vistagen Therapeutics, Inc., as Chief Corporate Development Officer from 2025.
Ms. Cote also formerly worked at Histogenics Corp., as Vice President-Marketing & External Relations and Sucampo Pharmaceuticals LLC, as Senior Vice President-Global Strategic Marketing from 2015 to 2018.
Ms. Cote received her undergraduate degree from Union College (New York).
Postes actifs de Elissa Cote
| Sociétés | Poste | Début |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 23/06/2025 |
Anciens postes connus de Elissa Cote
| Sociétés | Poste | Fin |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Sales & Marketing | 01/02/2018 |
| OCUGEN, INC. | Sales & Marketing | - |
Formation de Elissa Cote
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Union College (New York)
 Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
